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Abstract
Carboxylesterases hydrolyze chemicals containing such functional groups as a carboxylic acid ester,
amide and thioester. The liver contains the highest carboxylesterase activity and expresses two major
carboxylesterases: HCE1 and HCE2. In this study, we analyzed 104 individual liver samples for the
expression patterns of both carboxylesterases. These samples were divided into three age groups:
adults (≥ 18 years of age), children (0 days-10 years) and fetuses (82-224 gestation days). In general,
the adult group expressed significantly higher HCE1 and HCE2 than the child group, which expressed
significantly higher than the fetal group. The age-related expression was confirmed by RT-qPCR
and Western immunoblotting. To determine whether the expression patterns reflected the hydrolytic
activity, liver microsomes were pooled from each group and tested for the hydrolysis of drugs such
as oseltamivir and insecticides such as deltamethrin. Consistent with the expression patterns, adult
microsomes were ∼4 times as active as child microsomes and 10 times as active as fetal microsomes
in hydrolyzing these chemicals. Within the same age group, particularly in the fetal and child groups,
a large inter-individual variability was detected in mRNA (430 fold), protein (100 fold) and
hydrolytic activity (127 fold). Carboxylesterases are recognized to play critical roles in drug
metabolism and insecticide detoxication. The findings on the large variability among different age
groups or even within the same age group have important pharmacological and toxicological
implications, particularly in relation to pharmacokinetic alterations of ester drugs in children and
vulnerability of fetuses and children to pyrethroid insecticides.
1. Introduction
Carboxylesterases constitute a class of enzymes that hydrolyze chemicals containing such
functional groups as a carboxylic acid ester, amide and thioester [1]. These enzymes are known
to play important roles in drug metabolism and insecticide detoxication. Two major human
carboxylesterases (HCE1 and HCE2) are abundantly expressed in the liver, whereas HCE2 is
predominately expressed in the gastrointestinal tract [1,2]. In addition to the difference in tissue
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distribution, these two enzymes differ markedly in the hydrolysis of certain drugs. For example,
HCE1, but not HCE2, rapidly hydrolyzes the anti-influenza viral agent oseltamivir [3,4]. In
contrast, HCE2, but not HCE1, rapidly hydrolyzes the anticancer agent irinotecan [5]. In
addition to hydrolyzing numerous compounds, carboxylesterases catalyze transesterification.
In the presence of ethyl alcohol, HCE1 effectively converts the anti-platelet agent clopidogrel
(a methyl ester) into ethyl clopidogrel [4].
The expression of carboxylesterase is altered by xenobiotics and pathological conditions. In
human primary hepatocytes, therapeutic agents such as dexamethasone and phenobarbital
cause a slight or moderate induction of HCE1 and HCE2 [6]. Dexamethasone and phenobarbital
also alter the expression of rat carboxylesterases [7]. However, the pattern of the alteration is
different. Phenobarbital moderately induces rat carboxylesterases (hydrolase A and hydrolase
B), whereas dexamethasone profoundly suppresses the expression of these enzymes [7].
Suppression also occurs in human primary hepatocytes treated with the pro-inflammatory
cytokine interleukin-6 (IL-6), and the suppression is achieved by transcriptional repression
[8]. More importantly, the IL-6 mediated suppression strongly alters cellular responsiveness
to therapeutic agents such as clopidogrel, irinotecan, and oseltamivir [8]. Hydrolysis of
clopidogrel represents inactivation. In contrast, hydrolysis of irinotecan and oseltamivir leads
to the formation of therapeutically active metabolites thus represents activation [5,9].
The expression of carboxylesterases is regulated in a developmental manner, and it seems likely
that these enzymes are developmentally regulated in humans as well. One to two week old rats
express no hydrolase A or B based on immunoblotting analysis [7]. Consistent with the low
level expression of carboxylesterases, the intrinsic clearance of the pyrethroid deltamethrin
through hydrolysis in 10-day old rats is only ∼3% of adult rats [10]. Even in 4-week old rats,
the intrinsic clearance is less than half of that of adult rats [10]. In addition, young animals are
generally much more sensitive to pesticides such as organophosphates and pyrethroids
[11-13]. Carboxylesterases are known to protect against these chemicals by hydrolysis in the
case of pyrethroids or scavenging mechanism in the case of organophoaphates. The
developmental regulation of human carboxylesterases remains to be established. A previous
report by Pope et. al. [14] observed that infants differ from adults in the expression and
hydrolytic activity of carboxylesterases, but the difference was statistically insignificant [14].
The Pope's study, however, used a small number of samples and had only five samples for each
group.
In the current study, we analyzed a total of 104 individual liver samples for the expression
patterns of HCE1 and HCE2. These samples were grouped according to age: adults (>18 years
old), children (0-10) and fetuses. Multiple experimental approaches were used including RT-
qPCR, Western analysis and enzymatic assays. The fetuses expressed lower carboxylesterases
than the children, and the children expressed lower carboxylesterases than the adults. Overall,
the expression of both HCE1 and HCE2 showed a large inter-individual variability with the
largest variability in the fetal group.
2. Materials and Methods
2.1. Chemicals and supplies
Acetaminophen, aspirin, naproxen, and salicylic acid were purchased from Sigma (St. Louis,
MO). Clopidogrel and clopidogrel carboxylate were from ChemPacific (Baltimore, MD).
Oseltamivir and osel-tamivir carboxylate were from Toronto Research Chemicals (Canada).
Deltamethrin and permethrin were purchased from ChemService (West Chester, PA).
Deltamethrin had a purity of 99%, and permethrin was from a batch that contained a mixture
of cis- and trans-isomers at a ratio of 46 and 52%, respectively. TaqMan probes were from
Applied Biosystems (Foster City, CA). The antibody against glyceradehyde-3-phosphate
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dehydrogenase (GAPDH) was from Abcam (Cambridge, MA). Unless otherwise specified, all
other reagents were purchased from Fisher Scientific (Pittsburgh, PA).
2.2. Liver RNA and microsomal samples
A total of 104 RNA samples were used in this study and some of the RNA samples were
matched with microsomes. Pure RNA samples were purchased from (ADMET Technologies
(Durham, NC). Liver tissues were acquired from the National Disease Research Interchange
(Philadelphia, PA), the Midwest Transplant Network (Westwood, KS), the University of
Maryland Brain and Tissue Bank for Developmental Disorders (Baltimore, MD), and the
University of Washington Central Laboratory for Human Embryology (Seattle, WA). Isolation
of total RNA from the liver tissues was described previously [15,16], and the quality was
determined on an Experion RNA StdSens micro fluidic chip (Bio-Rad, Hercules, CA) or by
electrophoresis. Microsomes of child and fetal livers were prepared by differential
centrifugation as described previously [17]. Adult liver microsomes (individual samples) were
from CellzDirect (Pittsboro, NC) and described previously [4]. The demographics of the RNA
samples in each group are summarized in Table I. The use of the human samples was approved
by the Institutional Review Board.
2.3. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
Total RNA (0.1 μg) was subjected to the synthesis of the first strand cDNA in a total volume
of 25 μl with random primers and M-MLV reverse transcriptase. The reactions were conducted
at 25°C for 10 min, 42°C for 50 min and 70°C for 10 min. The cDNAs were then diluted 6
fold and quantitative PCR was performed with TaqMan Gene Expression Assay (Applied
Biosystems, Foster City, CA). The TaqMan assay identification numbers were: HCE1,
Hs00275607_m1 (NM_001266); HCE2, Hs00187279_m1 (NM_198061); and polymerase
(RNA) II, Hs01108291_m1 (NM_000937). It should be noted that the HCE1 probe could detect
both HCE1A1 and HCE1A2 transcripts. The PCR amplification was conducted in a total
volume of 20 μl containing universal PCR master mixture (10 μl), gene-specific TaqMan assay
mixture (1 μl), and cDNA template (3 μl). The cycling profile was 50°C for 2 min, 95°C for
10 min, followed by 40 cycles of 15 s at 95°C and 1 min at 60 °C, as recommended by the
manufacturer. Amplification and quantification were done with the Applied Biosystems
7900HT Real-Time PCR System. All samples were analyzed in triplicate and the signals were
normalized to polymerase (RNA) II [18] and then expressed as relative levels of mRNA among
all samples.
2.4. Western analysis
Microsomal proteins (1.5 μg) were resolved by 7.5% SDS-PAGE in a mini-gel apparatus and
transferred electrophoretically to nitrocellulose membranes. After non-specific binding sites
were blocked with 5 % non-fat milk, the blots were incubated with an antibody against HCE1,
HCE2 and GAPDH, respectively. The preparation of the antibodies against HCE1 and HCE2
was described elsewhere [6]. The primary antibodies were subsequently localized with goat
anti-rabbit IgG conjugated with horseradish peroxidase, and horseradish peroxidase activity
was detected with a chemiluminescent kit (SuperSignal West Pico). The chemiluminescent
signals were captured by a KODAK Image Station 2000 and the relative intensities were
quantified by the KODAK 1D Image Analysis Software.
2.5. Enzymatic assays
All enzymatic assays were carried out at 37°C in a total volume of 100 μl. Pilot studies were
performed to determine conditions (e.g., protein concentrations) to maintain the metabolism
in the linear range. Generally, microsomes (20-80 μg protein) were prepared in 50 μl incubation
buffer (phosphate buffer, 100 mM, pH 7.4; or Tris-HCl, 50 mM, pH 7.4) and then mixed with
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an equal volume of substrate solution (the same buffer). Hydrolysis of aspirin was performed
in phosphate buffer, whereas hydrolysis of oseltamivir, deltamethrin and permethrin was
carried out in Tris-HCl buffer. Aspirin was assayed at 1 mM, oseltamivir at 200 μM, both
deltamethrin and permethrin at 100 μM. The incubations lasted for 10-60 min depending on a
substrate, and the reactions were terminated with 150 μl of acetonitrile containing an internal
standard (IS): acetaminophen (750 ng/ml) for aspirin, clopidogrel carboxylate (50 ng/ml) for
oseltamivir, napronex (4 μg/ml) for deltamethrin and clopidogrel (33 μg/ml) for permethrin.
The reaction mixtures were subjected to centrifugation for 15 min at 4°C (15,000 g). Hydrolysis
of aspirin and oseltamivir was previously reported [3,4]. It should be noted that various controls
were performed such as 0-min incubation and incubation without microsomes.
2.6. Monitoring of hydrolysis by HPLC or LC-MS/MS
The hydrolysis of aspirin or pyrethroids was separated by High-performance liquid
chromatography (HPLC) (Hitachi LaChrom Elite-300) with a Chromolith SpeedROD column
RP-18e (Merck, Germany). The supernatants (10-30 μl) of the reaction mixtures were injected
and separated by an isocratic for aspirin or gradient mobile phase for deltamethrin and
permethrin. The isocratic mobile phase consisted of 12 % methanol and 0.25 % acetate acid at
pH 3.9 [4]. The gradient mobile phase consisted of acetonitrile and 0.01% formic acid. The
gradient was run at 20-50% acetonitrile (v/v) for 6 min, 50-80% for 3 min followed by 80-20%
for 6 min. Both mobile phases were run at a flow rate of 2 ml/min. For aspirin, the formation
of hydrolytic metabolite was monitored, whereas for deltamethrin and permethrin the
disappearance of parent compounds was monitored by a diode array detector at 230 nm. All
quantifications were performed using peak area ratios and calibration curves generated from
the internal control. The calibration curve ranged from 2 to 300 μg/mL with good linearity for
salicylic acid, 0.8 to 160 μg/mL for deltamethrin, and 0.6 to 120 μg/mL for permethrin.
The hydrolysis of oseltamivir was monitored by LC-MS/MS system (API 3200) as described
previously [3]. Briefly, the supernatants of the incubation mixtures were separated isocratically
using a mobile phase composition of 70:30% v/v acetonitrile : 0.05% v/v formic acid in
deionized water maintained at a flow rate of 0.25 ml/min with a total run time of 6.0 min.
Detection of the analytes was performed in positive ion mode using the mass transitions of m/
z: 313.3 → 166.1 for oseltamivir, m/z: 285.2→138.0 for oseltamivir carboxylate and m/z: 308.2
→ 152.0 for IS. Flow injection analysis was performed at a flow rate of 20 μl/min to obtain
optimum source parameters. The following compound parameters were used for oseltamivir,
oseltamivir carboxylate and IS, respectively. Declustering potential: +5, +5 and +30 V,
Focusing potential: +360 V each, Entrance potential: +8 V each, Collision cell entrance
potential: +20 V each, Collision energy: +25, +25 and +30 V and Collision cell exit potential:
+7 V each. The optimum source parameters that gave the highest oseltamivir intensity were
Curtain gas: 10 psi, Collision gas: 4 psi, Ion spray voltage: +5500 V, Temperature: 450°C, Ion
source gas1: 25 psi and ion source gas2: 85 psi. Integration of the peaks was performed by
manual baseline adjustment using the ANALYST SP version 1.2 software (Applied
Biosystems). All quantifications were performed using peak area ratios and calibration curves
consisted of oseltamivir or oseltamivir carboxylate to clopidogrel carboxylic acid
concentration ratios plotted against the oseltamivir or oseltamivir carboxylate to clopidogrel
carboxylic acid peak area ratios. The calibration curve ranged from 1 to 250 ng/mL with good
linearity for oseltamivir and 4 to 1000 ng/mL for oseltamivir carboxylate. The calibration
curves were constructed with 1/x2 weighting and the regression coefficients were greater than
0.99.
2.7. Other analyses
Protein concentrations were determined with BCA assay (Pierce) based on bovine serum
albumin standard. Data are presented as mean ± SD. All enzymatic assays were repeated three
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times with the same microsomal preparation. Statistical tests were performed to compare means
(Student's t test) or correlations (Spearman). In all cases, significant differences were assumed
when p values were less than 0.05.
3. Results
3.1. Ontogenic expression of human carboxylesterases HCE1 and HCE2 by RT-qPCR
In this study, we first evaluated the expression patterns of human carboxylesterases HCE1 and
HCE2 in various age groups. A total of 104 RNA samples were analyzed including 48 samples
from fetuses (82-224 gestation days), 34 from children (0 days-10 years of age) and 22 from
adults (≥18). The levels of HCE1 and HCE2 mRNA were determined with RT-qPCR, and the
results are summarized in Fig. 1 and Table II. Overall, the adult group had the highest levels
of HCE1 and HCE2 mRNA, and the fetal group had the lowest levels for both enzymes. Based
on the values of the means, the adult group expressed HCE1 at levels 319-fold higher than the
fetal group, and ∼50% higher than the child group (Fig. 1 and Table II). Likewise, the adult
group expressed HCE2 at levels 55-fold higher than the fetal group and ∼40% higher than the
child group. In all cases, the differences among various age groups were statistically significant
(Fig. 1). It should be noted that two different sets of Y axial values were used in Fig. 1 to
accommodate the large difference in the mRNA levels between the fetal and the other two
groups.
In addition to the large difference among various age groups (inter-group), a large inter-
individual variability was detected within a group. The fetal group, for example, showed a 431-
fold difference (ratio between the maximum and the minimum) in HCE1 mRNA with a
coefficient of variation (CV) of as high as 172% (Table II). The child and adult groups, on the
other hand, varied less in HCE1 mRNA with a 218- and 12-fold difference, respectively (Table
II). Similarly, the levels of HCE2 mRNA varied in all age groups, however, the overall
variability was much less than HCE1 mRNA. The variation in HCE2 mRNA was the same in
the fetal and child groups and higher than that in the adult group (21 versus 4 fold) (Table II).
We next examined whether the expression of carboxylesterases is age-related within a group.
The levels of mRNA were plotted against age or gestation days, and the correlation coefficients
were computed. The adult group showed no clear correlation for either HCE1 or HCE2 (data
not shown). In the fetal samples, the level of HCE2 but not HCE1 mRNA was significantly
correlated with age (Figs. 2A and B). In contrast, the child group showed better correlation
with age on HCE1 than HCE2 mRNA, although neither correlation reached the level of
statistical significance (Figs. 2C and D). To gain additional information on age-related
expression, correlation analysis was performed on the samples from donors under one year old
(0-1 year). In this sub-group, much improved correlation was observed on both HCE1 and
HCE2 with a p value of 0.004 and 0.111, respectively (Figs. 2E and F).
3.2. Inter-individual variability in carboxylesterase proteins and oseltamivir hydrolysis in the
child group
We next examined whether the levels of carboxylesterase mRNA reflected the levels of
corresponding proteins. RNA-microsome matched samples from 11 available pediatric-aged
subjects were evaluated. Fetal matched samples were not tested because of low mRNA
expression and low activities towards marker substrates (described below). No RNA-
microsome matched samples were available for the adult group. The microsomal samples were
first analyzed by Western immunoblotting with antibody against HCE1 or HCE2, and the
immunostaining intensities were quantified by the KODAK 1D Image Analysis Software. As
shown in Fig. 3A, all samples contained HCE1 and HCE2 proteins, but the relative abundance
varied markedly. In particular, one donor (lane 6) showed extremely low levels of both
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carboxylesterases (Fig. 3A). Based on the immunostaining intensities, HCE1 protein varied
by ∼100 fold, and HCE2 protein varied by ∼20 fold. The inter-individual variability, however,
was decreased to ∼8 fold for both carboxylesterases when the data-point (lane 6) was
eliminated. For both HCE1 and HCE2, the mRNA levels were correlated significantly with
the levels of respective proteins (p < 0.001) (Fig. 3B). The HCE1 matched samples had a
correlation coefficient of 0.9047, and the HCE2 matched samples had a slightly lower
correlation coefficient (0.8471) (Fig. 3B).
The large individual variability in carboxylesterase protein pointed to the possibility of marked
differences in the metabolism of therapeutic agents and other xenobiotics. To directly test this
possibility, the anti-influenza viral agent oseltamivir (an ester prodrug) was incubated with
individual donor samples (Fig. 3A), and the hydrolysis was monitored. As shown in Fig. 3C,
all samples hydrolyzed this anti-viral agent, and the overall hydrolysis varied by 127-fold. Such
a large inter-individual variability was in agreement with the variation in the abundance of
HCE1 (Fig. 3A), which has been shown to catalyze the hydrolysis of oseltamivir (3). As
expected, sample 6 (lane 6) contained the lowest HCE1 protein and showed the lowest
hydrolytic activity toward oseltamivir. Conversely, sample 7 (lane 7) contained the highest
level of HCE1 protein and was the most active toward this anti-viral agent (Figs. 3A and C).
The hydrolysis of oseltamivir among these individual samples was highly correlated with the
protein level of HCE1 with a correlation coefficient of 0.9373, although samples 8 and 10
exhibited relatively lower hydrolysis compared with their relatively HCE1 contents (Figs. 3A
and C).
3.3. Hydrolysis of drugs and insecticides by liver microsomes of fetuses, children and adults
We next extended the metabolism study to include the anti-inflammatory agent aspirin, and
insecticides permethrin (cis- and trans-) and deltamethrin. In addition to their pharmacological
and toxicological implication, these chemicals were chosen because they are hydrolyzed in an
isoform-specific manner. Oseltamivir and deltamethrin are predominately hydrolyzed by
HCE1 [3,19-21], whereas aspirin is predominately hydrolyzed by HCE2 [4]. The cis-form of
permethrin is favorably hydrolyzed by HCE2, whereas the trans-form is comparably
hydrolyzed by both forms [19]. The extended metabolism study was performed with
microsomes pooled from various age groups, and the microsomes were so pooled by mixing
equal amount from all individuals in an age group. The pooled samples enabled comparison
to be made on the overall hydrolysis of these chemicals among different age groups.
We first determined the levels of HCE1 and HCE2 in the pooled samples by Western
immunoblotting. Based on the immunostaining intensities, the child group expressed ∼25% of
carboxylesterases (both HCE1 and HCE2) of the adult group and the fetal group expressed less
than 10% of the adult group (Fig. 4A). Overall, the magnitude of hydrolysis of these chemicals
was correlated well with the relative levels of carboxylesterases in these samples (Figs. 4B-F).
The adult pooled sample showed the highest activity toward all chemicals and the fetal pooled
samples showed the lowest activity. Hydrolysis of aspirin and trans-permethrin (Per-1) by the
samples pooled from the fetuses and children was slightly higher than that predicted according
to their relative abundance of carboxylesterases. For example, the fetal sample contained less
than 10% of carboxylesterases of the adult sample but showed 25% of aspirin hydrolysis (Figs.
4A and C). Conversely, the hydrolysis of oseltamivir, cis-permethrin and deltamethrin by the
fetal group was less than 10% of the adult group. The precise mechanism on these discrepancies
remains to be determined. On the other hand, the higher-than predicted hydrolysis, in the case
of aspirin, was likely due to hydrolysis by other enzymes (highly expressed in the fetal liver)
or due to polymorphic variants. In support of these possibilities, butyrylcholinesterase has been
shown to hydrolyze aspirin [22], and certain polymorphic variants of HCE2 were found to
differ from the wild-type enzyme in hydrolyzing this anti-platelet agent [4]. In addition, the
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liver expresses a third carboxylesterase [23], but it remains to be determined whether this
carboxylesterase hydrolyzes these compounds (i.e., aspirin and trans-permethrin) and whether
the expression of this carboxylesterase is developmentally regulated.
4. Discussion
Carboxylesterases constitute a class of hydrolytic enzymes that play important roles in the
metabolism of therapeutic agents and detoxication of insecticides [1]. In this study, we analyzed
a large number of individual liver samples for the expression patterns of HCE1 and HCE2, two
human carboxylesterases predominately expressed in the liver. Overall, the adult group
expressed significantly higher HCE1 and HCE2 than the child group or the fetal group. The
age-related expression was confirmed on the levels of both mRNA and protein. In agreement
with the expression patterns, the adult microsomes were approximately 4 times as active as the
child microsomes and more than 10 times as active as the fetal microsomes in hydrolyzing a
group of therapeutic agents and insecticides. Even within the same age group, a large inter-
individual variability was detected in mRNA and protein levels as well as hydrolytic activity.
Although both HCE1 and HCE2 exhibited a similar expression pattern among the various age
groups, there were several major differences. First, HCE1 exhibited much greater inter-group
and inter-individual variability than HCE2. For example, based on the values of the means, the
adult group displayed a 319-fold higher level in HCE1 mRNA compared with the fetal group.
In contrast, these two groups showed only a 55-fold difference in the level of HCE2 mRNA
(Fig. 1 and Table II). Likewise, the adult group showed a 430-fold inter-individual variability
in HCE1 mRNA (ratio between maximum over minimum), in contrast, only a 21-fold
difference in HCE2 mRNA was detected in the same group (Table II). Second, HCE1 displayed
better age-related expression than HCE2 in the child group with correlation coefficients of
0.3138 and 0.1058, respectively (Figs. 2C and D). In contrast, HCE2 displayed better
correlation in the fetal group with correlation coefficients of 0.4362 and 0.1136, respectively
(Figs. 2A and B).
The large inter-individual variability, particularly in the fetal and children groups, was likely
an outcome coordinated by multiple mechanisms. In this study, we have shown that the adult
group expressed the highest levels of HCE1 and HCE2 followed by the child group, and the
fetal group expressed the lowest levels of both enzymes (Fig. 1 and Table II). Such age-related
expression patterns were confirmed by RT-qPCR and Western analyses (Figs. 1, 3 and 4) and
established that developmental regulation is involved in the expression of HCE1 and HCE2.
However, the correlation with age in many cases was only moderate at the most and did not
reach the levels of statistical significance (Figs. 2C and F). Although the precise mechanisms
remain to be determined, the lack of strong correlation with age in these groups was likely due
to complicated factors such as the administration of therapeutic agents and disease conditions.
We have previously reported that pathological condition and therapeutic agents markedly
altered the expression of HCE1 and HCE2 [6,8]. Interleukin-6, a cytokine usually elevated
during inflammation, profoundly suppressed the expression of both HCE1 and HCE2 (8).
Consistent with the suppression of carboxylesterases by cytokines, patients with elevated
cytokine conditions such as liver cirrhosis had much lower capacity of hydrolyzing ester drugs
such as perindopril, a non-sulphydryl angiotensin converting enzyme inhibitor [24,25].
The significantly lower level of HCE1 in the child group, compared with the adult group,
provides a molecular explanation to the large pharmacokinetic difference in oseltamivir
between these two groups. In this study, the sample pooled from the children was only ∼15%
as active as the sample pooled from the adults in hydrolyzing oseltamivir (Fig. 4C). Consistent
with the in vitro metabolism, children under 12 years old reportedly produced only
approximately half of the hydrolytic metabolite produced by adults [26]. Apparently the low
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level production of oseltamivir carboxylate in children was likely due to ineffective hydrolysis
of the parent drug and higher clearance of the metabolite. Furthermore, we have shown that
individual samples in the child group varied by as many as 127-fold in oseltamivir hydrolysis
(Fig. 4A). Pharmacokinetic studies in children, however, did not detect such a large inter-
individual variation in the production of hydrolytic metabolite of oseltamivir [26,27]. One
explanation is that the frequency with an extremely low expression level of HCE1 is rare in
the general population, and the pharmacokinetic studies were performed in 24 or fewer children
[26,27]. Indeed, there was a reported rare case that an adult patient with diabetes mellitus had
only 1-2% capacity of normal people in hydrolyzing clopidogrel based on the values of the
means and standard deviations [28]. Like oseltamivir, clopidogrel is a substrate of HCE1 [3].
Ineffective hydrolysis of oseltamivir, on the other hand, likely leads to increased concentration
in the brain. Some patients taking oseltamivir reportedly developed neurobehavioral changes
[29], although a direct link remains to be established between the developed neurotoxiciy and
the use of oseltamivir.
In contrast to oseltamivir, pyrethroids have long been recognized to exert neurotoxicity [30].
As a class of the most used insecticides in the world, both the general population and workers
have a high risk to be exposed to these insecticides. Epidemiological studies have shown that
the exposure level, in some cases, can be high [31,32]. Pyrethroid insecticides are generally
considered safe to mammals, because they are rapidly eliminated by carboxylesterases. In this
study, we have shown that the fetuses and children hydrolyzed pyrethroids at a rate of only
∼20% or lower of the adults (Figs. 4D-F), suggesting their vulnerability to pyrethroids-induced
toxicity. In support of this notion, neonatal rats were reportedly 17 times as sensitive as adult
rats to cypermethrin [12]. Neurotoxicity induced by pyrethroids appears to cause irreversible
damage. Prenatal exposure to deltamethrin, for example, led to a deficit in locomotor activity
of offspring post-natally at 9 weeks [33]. In humans, micromolar concentrations were reported
in the meconium [34]. This is particularly of relevance as fetuses have only limited capacity
of hydrolytic detoxication as described in this report.
In summary, our work points to several important conclusions. First, the expression of both
HCE1 and HCE2 increases with age, establishing that their expression is developmentally
regulated and that fetuses and children generally have lower capacity of hydrolytic metabolism
than adults. Second, there is a large inter-individual variability in the expression of these
enzymes, particularly in the fetal and child groups. It is likely that the expression of HCE1 and
HCE2 in these age groups is subjected to non-developmental regulation with high sensitivity
(e.g., xenobiotic regulation). Carboxylesterases are recognized to play important roles in drug
metabolism and insecticide detoxication. The findings on the large variability among different
age groups or even within the same age group have important pharmacological and
toxicological implications, particularly in relation to altered pharmacokinetics of ester drugs
in children and vulnerability of fetuses and children to insecticides such as pyrethroids.
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Abbreviation
GAPDH  
glyceradehyde-3-phosphate dehydrogenase
HCE  
human carboxylesterase
HPLC  
High-performance liquid chromatography
PBS  
phosphate buffered saline
RT-qPCR  
reverse transcription-quantitative polymerase chain reaction
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Fig. 1. Levels of HCE1 and HCE 2 mRNA in the adult, child and fetal groups
Total RNAs were subjected to RT-qPCR analysis for the level of HCE1 mRNA (A) and HCE2
mRNA (B) by Taqman probes as described in the section of Materials and Methods. The adult
group contained 22 samples, the child group contained 34 samples and the fetal group contained
48 samples. The signals from each target were normalized based on the signal from PolII and
expressed as relative levels among all samples. The data are presented as mean ± SD *Statistical
significance at p < 0.05, **Statistical significance at p < 0.001.
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Fig. 2. Age-related expression of HCE1 and HCE2
The data from Fig. 1 were plotted against age with SPSS version 16. (A) Correlation of HCE1
mRNA with gestation days. (B) Correlation of HCE2 mRNA with gestation days. (C)
Correlation of HCE1 mRNA with age in the child group (0-10 years old). (D) Correlation of
HCE2 mRNA with age in the child group (0-10 years old). (E) Correlation of HCE1 mRNA
with age in the sub-child group (0-1 year old). (F) Correlation of HCE2 mRNA with age in the
sub-child group (0-1 year old) *Statistical significance (p < 0.05).
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Fig. 3. Individual variation of HCE1 and HCE2 proteins and oseltamivir hydrolysis in the child
group
(A) Western analyses Microsomes (1.5 μg) were resolved by 7.5% SDS-PAGE and transferred
electrophoretically to nitrocellulose membranes. The blots were incubated with an antibody
against HCE1, HCE2 or GAPDH and chemiluminescent substrate. The signal was captured by
a KODAK Image Station 2000 and the relative intensities were quantified by the KODAK 1D
Image Analysis Software. (B) Correlation analyses The immunointensities of HCE1 and HCE2
were plotted against the levels of respective mRNA. The correlation coefficients and
evaluations on statistical significance were performed with SPSS version 16. * Statistical
significant (p < 0.001). (C) Oseltamivir hydrolysis by individual liver samples of the child
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group Microsomes (20 μg) were incubated with oseltamivir (200 μM) at 37°C for 10 min, and
the formation of oseltamivir carboxylate was detected by LC-MS/MS. Data were assembled
from three independent experiments with two injections of each experiment.
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Fig. 4. Hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin
(A) Western analysis of pooled samples for various groups Microsomes (1.5 μg) pooled from
the adult, child and fetal group were analyzed by Western blotting and the immunostaining
intensities were quantified by the KODAK 1D Image Analysis Software. (B) Hydrolysis of
oseltamivir by pooled microsomes. Microsomes (20 μg) from various age groups were
incubated with oseltamivir (200 μM) at 37°C for 10 min, and the formation of oseltamivir
carboxylate was detected by LC-MS/MS. (C) Hydrolysis of aspirin by pooled microsomes
Microsomes (80 μg) from various age groups were incubated with aspirin (1 mM) at 37°C for
60 min, and the formation of salicylic acid was detected by HPLC. (D and E) Hydrolysis of
permethrin by pooled microsomes Microsomes (50 μg) from various age groups were incubated
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with permethrin (100 μM) at 37°C for 60 min, and the disappearance of the parent compounds
was detected by HPLC. Permethrin contained a mixture of cis- and trans-isomers at a ratio of
46 and 52%, respectively with the cis-form having a retention time of 10.41 and the trans-form
of 10.18. (F) Hydrolysis of deltamethrin by pooled microsomes Microsomes (50 μg) from
various age groups were incubated with deltamethrin (100 μM) at 37°C for 60 min, and the
disappearance of the parent compound was detected by HPLC. Data were assembled from three
independent experiments with each experiment having two injections.
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